Concepedia

Publication | Open Access

Targeting m <sup>6</sup> A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer

241

Citations

23

References

2023

Year

Abstract

YTHDF1 impairs antitumour immunity via an m<sup>6</sup>A-p65-CXCL1/CXCR2 axis to promote CRC and serves as a therapeutic target in immune checkpoint blockade therapy.

References

YearCitations

Page 1